Literature DB >> 6280426

ACTH-producing pituitary adenomas in Addison's disease: two cases treated by transsphenoidal microsurgery.

B Krautli, J Müller, A M Landolt, F von Schulthess.   

Abstract

In 2 women with known Addison's disease, progressive hyperpigmentation reappeared years after an initial remission under conventional substitution therapy with cortisone. Excessively elevated plasma ACTH concentrations and radiological evidence of sella turcica deformation led to the diagnosis of ACTH-producing adenomas and prompted their removal by transsphenoidal microsurgery. In one patient, a large Crooke's cell adenoma with extensive extrasellar expansion had caused severe and irreversible bilateral defects of the visual fields and unilateral optic atrophy. Surgical removal of the tumour and radiotherapy brought about a permanent disappearance of the hyperpigmentation, but eventually led to secondary hypothyroidism. In the second patients, the selective removal of a small intrasellar eosinophilic adenoma consisting of ACTH-producing cells did not alleviate the hyperpigmentation and did not lower the plasma ACTH concentration. However, hyperpigmentation regressed markedly within a year of treatment with a higher dose of cortisone. The rarity of similar cases in the literature seems to indicate that insufficient feedback suppression of ACTH-producing cells in treated Addison's disease does not by itself induce the development of a pituitary adenoma, but might promote the growth of an independently and coincidentally occurring microadenoma, which would have caused Cushing's disease in a person with intact adrenal glands.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280426     DOI: 10.1530/acta.0.0990357

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

1.  Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.

Authors:  S C Tung; P W Wang; T L Huang; W C Lee; W J Chen
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

2.  Subclinical Addison's disease mimicking a silent corticotroph adenoma.

Authors:  P Iglesias; J J Díez
Journal:  J Endocrinol Invest       Date:  2011-10       Impact factor: 4.256

3.  Clinical manifestations and hormonal profile of two women with Cushing's disease and mild deficiency of 21-hydroxylase.

Authors:  M Boronat; A Carrillo; A Ojeda; J Estrada; B Ezquieta; F Marín; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

4.  Addison's disease and empty sella.

Authors:  B Ambrosi; E Riva; R Ferrario; G Faglia
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

Review 5.  Addison's disease with pituitary hyperplasia: a case report and review of the literature.

Authors:  Jiaqiang Zhou; Lingxiang Ruan; Hong Li; Qingqing Wang; Fenping Zheng; Fang Wu
Journal:  Endocrine       Date:  2009-04-09       Impact factor: 3.633

6.  Pituitary Corticotroph Adenoma in a Woman with Long-Standing Addison's Disease: A Histologic, immunocytochemical, Electron Microscopic, and In Situ Hybridization Study.

Authors:  Kalman Kovacs; Lucia Stefaneanu; Eva Horvath; Michael Buchfelder; Rudolph Fahlbusch; Peter H. Althoff; Christine Moore
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.